EMA: Concept paper on the need for revision of note for guidance on clinical investigation of medicinal products for the treatment of cardiac failure - Draft

Chronic Heart Failure (CHF) encompasses heterogeneous groups of patients with a wide spectrum of symptoms and different causes. The CHMP Guideline on the clinical investigations of medicinal products for the treatment of cardiac failure (CPMP/EWP/235/95) addresses the development issues in this specific patient population.